Preliminary reliability of the FACT-RNT in standard-of-care Lu-PSMA therapy of metastatic castration-resistant prostate cancer.

被引：0
|
作者：
Gudenkauf, Lisa Marie
Murthy, Vishnu
Lam, Ethan C.
Li, Xiaoyin
Gardner, Linda
Tagawa, Scott T.
Dicker, Adam P.
Cella, David
Czernin, Johannes
Calais, Jeremie
Gonzalez, Brian D.
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ Calif Los Angeles, Mt House, CA USA
[3] Univ Calif Los Angeles, Ahmanson Translat Theranost Div, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Los Angeles, CA USA
[5] New York Presbyterian Hosp, Div Hematol & Med Oncol, Weill Cornell Med, New York, NY USA
[6] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA USA
[7] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA
[8] Univ Calif Los Angeles, Dept Nucl Med, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
261-492-199; 130-3426-3529; 261-492-6491; 283-2494-5577-2829-12292; 261-436; 2;
D O I：
10.1200/JCO.2024.42.4_suppl.99
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients
    Cytawa, Wojciech
    Hendel, Robin
    Tomasik, Bartlomiej
    Weinzierl, Franz-Xaver
    Bley, Thorsten
    Jassem, Jacek
    Schirbel, Andreas
    Buck, Andreas K.
    Bundschuh, Ralph A.
    Hartrampf, Philipp E.
    Werner, Rudolf A.
    Lapa, Constantin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (12) : 3765 - 3776
  • [32] Single-lesion PSMA protein expression and response to Lu-177 PSMA therapy in patients with castration-resistant prostate cancer.
    Stangl-Kremser, Judith
    Rasul, Sazan
    Tosoian, Jeffrey J.
    Salami, Simpa
    Zaslavsky, Alexander
    Udager, Aaron M.
    Mazal, Peter
    Kain, Renate
    Comperat, Eva
    Salido, Carmen Pozo
    Steinbach, Christina
    Hassler-Di Fratta, Melanie
    Kramer, Gero
    Shariat, Shahrokh
    Palapattu, Ganesh S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] 177Lu-PSMA-I&T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer:FirstClinical trialin Asia
    Bu, Ting
    Zhang, Pengjun
    Zang, Shiming
    Zhang, Lulu
    Wang, Feng
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [34] [177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer reply
    Hofman, Michael S.
    Violet, John
    Hicks, Rodney J.
    Sandhu, Shahneen
    LANCET ONCOLOGY, 2018, 19 (08): : E373 - E373
  • [35] Treatment efficacy and safety of 177Lu-PSMA Radioligand Therapy in Octogenarians with metastatic castration-resistant prostate cancer
    Langbein, T.
    Retz, M.
    D'Alessandria, C.
    Grigorascu, S.
    Hansen, K.
    Wester, H.
    Gschwend, J.
    Weber, W.
    Eiber, M.
    Tauber, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S132 - S133
  • [36] 177Lu-EB-PSMA Radioligand Therapy with Escalating Doses in Patients with Metastatic Castration-Resistant Prostate Cancer
    Zang, Jie
    Liu, Qingxing
    Sui, Huimin
    Wang, Rongxi
    Jacobson, Orit
    Fan, Xinrong
    Zhu, Zhaohui
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (12) : 1772 - 1778
  • [37] 177Lu-PSMA and 177Lu-DOTATATE Therapy in a Patient With Metastatic Castration-Resistant Prostate Cancer and Neuroendocrine Differentiation
    Assadi, Majid
    Pirayesh, Elahe
    Rekabpour, Seyed Javad
    Zohrabi, Farshad
    Jafari, Esmail
    Nabipour, Iraj
    Esmaili, Abdolhamid
    Amini, Abdullatif
    Ahmadzadehfar, Hojjat
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (12) : 978 - 980
  • [38] Efficacy and Safety of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients
    Yadav, Madhav Prasad
    Ballal, Sanjana
    Bal, Chandrashekhar
    Sahoo, Ranjit Kumar
    Damle, Nishikant Avinash
    Tripathi, Madhavi
    Seth, Amlesh
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (01) : 19 - 31
  • [39] 177Lu-EB-PSMA radioligand therapy with escalating doses in patients with metastatic castration-resistant prostate cancer
    Zang, Jie
    Liu, Qingxing
    Sui, Huimin
    Wang, Rongxi
    Jacobson, Orit
    Zhu, Zhaohui
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [40] Re-Rechallenge 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
    Aggarwal, Piyush
    Gunasekaran, Vinisha
    Sood, Ashwani
    Kumar, Narendra
    Rathore, Yogesh
    Kumar, Rajender
    Mittal, Bhagwant Rai
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (03) : 231 - 233
12345